ACADIA PHARMACEUTICALS INC【ACAD】Balance sheet

Market cap

$4.5B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	7	58	12	62	102	164	69	135	190	326	147	115	189	320
Marketable securities, current	48	100	174	261	113	365	272	339	508	306	373	302	250	436
Total cash & short-term investments	55	158	186	322	215	529	341	474	697	632	521	417	439	756
Accounts receivable, net	-	-	-	-	-	6	17	26	36	48	64	62	98	99
Inventories	-	-	-	-	-	4	5	4	6	10	-	-	-	-
Total current assets	32	109	188	325	219	548	373	526	760	718	618	508	616	938
Property, plant and equipment, net	0	0	1	1	2	3	3	3	3	9	8	6	5	4
Total non-current assets	0	0	1	1	3	13	11	14	23	65	82	80	133	249
Total assets	32	109	189	325	222	561	385	540	783	783	700	588	749	1,188
Accounts payable	2	1	0	2	2	4	9	3	7	8	7	13	18	16
Long-term debt, current	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities	6	6	7	16	22	43	49	60	75	106	96	126	254	395
Total non-current liabilities	3	-	0	0	0	0	0	2	9	50	63	62	63	60
Total liabilities	9	6	7	16	22	43	49	61	84	156	159	187	317	455
Common stock and paid-in capital	370	453	588	808	862	1,452	0	0	0	0	0	0	0	0
Retained earnings	-347	-368	-406	-498	-663	-934	-1,224	-1,469	-1,704	-1,986	-2,154	-2,370	-2,431	-2,204
Stockholders' equity	23	85	182	309	200	518	335	479	699	627	541	400	432	733
Total debt	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-55	-	-	-	-	-	-	-	-	-	-	-	-	-
D/E ratio (%)	0.1	-	-	-	-	-	-	-	-	-	-	-	-	-
Working capital	-	-	-	-	-						-	-	-	-